Dsm N.v.

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Dsm N.v. Company Summary

COMPANY DATA

	Homepage	www.dsm.com

---

Key Developments: Dsm N.v.

	DSM N.V. (AMS:DSM) DSM Scientist Selected For Joseph J. Mattiello Lecture 2009 OCT 29, 2008 20:19 - Article Views: 214 DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that Ad Overbeek, Global Science Manager DSM NeoResins+, has been selected by The Federation of Societies for Coatings Technology (FSCT) to deliver the 2009 Joseph J. Mattiello Memorial Lecture.
	DSM N.V. (AMS:DSM) DSM Reports Strong Q3 Against Deteriorating Market Conditions OCT 27, 2008 17:19 - Article Views: 258 DSM N.V. (AMS:DSM) * Continued strong organic sales growth (12%), driven by pricing power. * Sustained strong profitability in Nutrition. * Accelerating economic downturn increasingly visible in Materials Sciences. * EBIT from continuing operations up 27% to EUR 267 million; EPS up 41%. * 2008 operating profit expected to be around EUR 1,000 million.
	DSM N.V. (AMS:DSM) DSM Continues Partnership With Dutch Olympic Committee OCT 25, 2008 00:17 - Article Views: 244 DSM N.V. (AMS:DSM) DSM and the Dutch Olympic Committee/Dutch Sports Federation (NOC*NSF) will continue to be 'Partners in Sports' in the run-up to the London 2012 Olympics. The partners have today signed an agreement to this effect at the Papendal Dutch National Sports Centre. As innovation partner of NOC*NSF, DSM is supporting the Dutch Olympic team with innovations in the field of nutrition and materials in order to help the team achieve top performances.
	DSM N.V. (AMS:DSM) DSM Verlengt Partnerschap Met NOC*NSF OCT 25, 2008 00:17 - Article Views: 279 DSM N.V. (AMS:DSM) DSM en NOC*NSF zetten hun samenwerking als 'Partner in Sport' voort richting de Olympische Spelen in Londen 2012. De partners ondertekenden daartoe vandaag op Papendal een contract. Als innovatiepartner van NOC* NSF ondersteunt DSM het Nederlands Olympisch Team met nieuwe producten op het gebied van voeding en materialen om hiermee een bijdrage te leveren aan het behalen van topprestaties.
	DSM N.V. (AMS:DSM) DSM Launches U.S. Department Of Energy-funded Research Initiative For Second Generation Biofuels OCT 21, 2008 17:17 - Article Views: 195 DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company today announced the execution of a multimillion dollar cooperative funding agreement with the US Department of Energy to underwrite a portion of research and development costs aimed at enabling "second generation" biofuels from non-food feedstocks.
	DSM N.V. (AMS:DSM) DSM And WFP Win 2008 ICIS Business Innovation Award OCT 14, 2008 19:17 - Article Views: 292 DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and the United Nations World Food Programme (WFP) announce that the 2008 ICIS Innovation Awards for Best Business Innovation has been awarded to DSM Nutritional Products and WFP for the MixMe (TM) micronutrient powder.
	DSM N.V. (AMS:DSM) DSM Invests In Incubator To Strengthen Position In Biomedical Materials OCT 13, 2008 16:17 - Article Views: 201 DSM N.V. (AMS:DSM) DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has made an investment in the new business incubator in the field of medical devices Accelerated Technologies II, L.P. (ATP). The investment further strengthens DSM's position in the biomedical materials market, one of the Emerging Business Areas defined in its Vision 2010 - Building on Strengths strategy. Financial details will not be disclosed.
	DSM N.V. (AMS:DSM) DSM Anti-Infectives To Close Clavulanic Acid Production Site In Sweden OCT 2, 2008 16:17 - Article Views: 246 DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Anti-Infectives has decided to close its site in Strängnäs, Sweden. The site mainly produces clavulanic acid. Total cost of closure will be slightly above EUR 10 million (after tax) and will be reported as an exceptional item in Q4.
	DSM N.V. (AMS:DSM) DSM Publishes DNA Genome Sequence Of Penicillin Producer Penicillium chrysogenum SEP 29, 2008 19:17 - Article Views: 439 DSM N.V. (AMS:DSM) Major landmark in the 80 year history of Penicillin
	DSM N.V. (AMS:DSM) DSM Invests In Intelligent Medication Packaging SEP 26, 2008 16:19 - Article Views: 220 DSM N.V. (AMS:DSM) DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has made an equity investment in The Compliers Group International B.V. (TCG). The Netherlands-based company focuses on the development of smart pharmaceutical packaging solutions that contain microchips which enable the monitoring of a patient's therapy compliance. Financial details of the investment will not be disclosed.

329 COMPANY PROFILE VIEWS

This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 28) (Since Published: 329)